Singapore, Aug 16, 2010: Cleveland Clinic has finalized the agenda for the 8th Annual Medical Innovation Summit, which will be held Nov. 1-3 on the Clinic's campus. The Summit draws 1,000 attendees each year, and includes panel discussions with some of the industry's top CEOs and thought leaders.

This year's summit will highlight breakthrough technologies for diagnosing and treating obesity and diabetes. Top executives, investors, entrepreneurs, clinicians and technologists will gather to share ideas on how to combat this devastating epidemic.

"Since 1980, obesity rates have doubled in the United States, not only increasing the likelihood of diabetes, but also a number of other significant health risks," said Chris Coburn, Executive Director of Cleveland Clinic Innovations. "This year's summit brings together the decision makers who are developing new technologies to diagnose, treat and manage these diseases. We have assembled the top executives, highest impact technologies, most active investors and leading clinicians to highlight the issues and opportunities for this important area of medical innovation."

The 2010 Medical Innovation Summit will feature more than 40 international leaders including: CEOs Bill Weldon (Johnson & Johnson), Chris Viehbacher (Sanofi-aventis), John Lechleiter (Eli Lilly), Kevin Sharer (Amgen), John Hammergren (McKesson), William Hawkins (Medtronic), Stephen MacMillan (Stryker), Rich Meelia (Covidien), Angela Braly (Wellpoint), and Tim Ring (Bard).